Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review.

Most models were not suitable for clinical use due to methodological shortcomings and lack of external validation. Further external validation and/or model updating is required to increase prognostic accuracy and clinical applicability prior to their incorporation in clinical practice as a useful tool in patient management.